Sartorius Stedim Biotech SA: Half-year report of the liquidity contract with the stockbroker company Gilbert Dupont
Sartorius Stedim Biotech SA
Aubagne, France, July 2, 2020
Half-year report of the liquidity contract with the stockbroker company Gilbert Dupont
Under the liquidity contract concluded between SARTORIUS STEDIM BIOTECH and the stockbroker Gilbert Dupont, the following assets appeared on the liquidity account on June 30, 2020:
During the first half of 2020, the following were negotiated:
It should be noted that in the second half of 2019, which ended December 31, 2019, the following assets appeared on the liquidity account:
It should also be noted that upon implementing the liquidity contract, the following assets were made available:
A profile of Sartorius Stedim Biotech Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In 2019, the company employed approx. 6,200 people, and earned sales revenue of €1,440.6 million. Contact Ben Orzelek Head of Investor Relations +49 (0)551.308.1668
Sartorius Stedim Biotech S.A. Z.I. Les Paluds Avenue de Jouques, CS 91051 13781 Aubagne Cedex, France Phone: +33.(0)4.42.84.56.00 Fax: +33.(0)4.42.84.56.19 www.sartorius-stedim.com
Regulatory filing PDF file File: Half-year report of the liquidity contract with the stockbroker company Gilbert Dupont |
Language: | English |
Company: | Sartorius Stedim Biotech SA |
Avenue de Jouques | |
13781 Aubagne | |
France | |
Phone: | +33 44 284 5600 |
E-mail: | [email protected] |
Internet: | www.sartorius-stedim.com |
ISIN: | FR0013154002 |
Euronext Ticker: | DIM |
AMF Category: | Share buyback / Disposal of own shares / Information relating to the liquidity contract |
EQS News ID: | 1084849 |
End of Announcement | EQS News Service |
1084849 02-Jul-2020 CET/CEST